000 | 01247 a2200325 4500 | ||
---|---|---|---|
005 | 20250516205345.0 | ||
264 | 0 | _c20150112 | |
008 | 201501s 0 0 eng d | ||
022 | _a1549-490X | ||
024 | 7 |
_a10.1634/theoncologist.2014-038 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJohnston, Patrick G | |
245 | 0 | 0 |
_aIdentification of clinically relevant molecular subtypes in colorectal cancer: the dawning of a new era. _h[electronic resource] |
260 |
_bThe oncologist _cMay 2014 |
||
300 |
_a568-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aColorectal Neoplasms _xclassification |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Medicine |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xgenetics |
650 | 0 | 4 | _aProto-Oncogene Proteins p21(ras) |
650 | 0 | 4 |
_aras Proteins _xgenetics |
773 | 0 |
_tThe oncologist _gvol. 19 _gno. 5 _gp. 568-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.2014-038 _zAvailable from publisher's website |
999 |
_c23723943 _d23723943 |